| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |